HER-2 G778_P780dup
|
Breast Cancer
|
HER-2 G778_P780dup
|
Breast Cancer
|
HM 78136B Sensitive: D – Preclinical
Cancer Res - 1 week (New D)
|
HM 78136B Sensitive: D – Preclinical
Cancer Res - 1 week - (New D)
|
HER-2 G778_P780dup
|
NSCLC
|
HER-2 G778_P780dup
|
NSCLC
|
dacomitinib Sensitive: C3 – Early Trials
|
dacomitinib Sensitive: C3 – Early Trials
|
HER-2 G778_P780dup
|
LUAD
|
HER-2 G778_P780dup
|
LUAD
|
afatinib Sensitive: C4 – Case Studies
|
afatinib Sensitive: C4 – Case Studies
|